LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 77,178 Value ($000) $42 Avg Close Range
Q4 2024
Shares 966,265 Value ($000) $618 Avg Close Range
Q3 2024
Shares 472,626 Value ($000) $652 Avg Close Range
Q2 2024
Shares 400,853 Value ($000) $581 Avg Close Range
Q1 2024
Shares 373,606 Value ($000) $833 Avg Close Range
Q1 2023
Shares 16,353 Value ($000) $39 Avg Close Range
Q4 2022
Shares 59,865 Value ($000) $208 Avg Close Range
Q3 2022
Shares 107,235 Value ($000) $786 Avg Close Range
Q2 2022
Shares 268,842 Value ($000) $1,753 Avg Close Range
Q1 2022
Shares 323,246 Value ($000) $1,632 Avg Close Range
Q4 2021
Shares 162,070 Value ($000) $1,254 Avg Close Range